HomeTwitterJefferies Managing Dir. Michael Yee on $MRNA: “The overly high expectations and significant valuation is going to lead to challenges in 2022, and I think there’s going to be a lot of money flow out of this name as people digest what’s next for the company beyond COVID vaccines.”

January 19, 2022

Jefferies Managing Dir. Michael Yee on $MRNA: “The overly high expectations and significant valuation is going to lead to challenges in 2022, and I think there’s going to be a lot of money flow out of this name as people digest what’s next for the company beyond COVID vaccines.”

Jefferies Managing Dir. Michael Yee on $MRNA: "The overly high expectations and significant valuation is going to lead to challenges in 2022, and I think there's going to be a lot of money flow out of this name as people digest what's next for the company beyond COVID vaccines." pic.twitter.com/6s3dm9lus3

— Yahoo Finance (@YahooFinance) January 19, 2022

Related posts

Glencore will pay about $1.5 billion and admitted to bribery and market manipulation to settle US, UK, and Brazilian probes.

U.S. retailer Kohl’s bidders are preparing to make binding offers that are lower than the indicative bids they submitted earlier this year

A driverless electric truck developed by Swedish freight technology company Einride recently demonstrated its precision by autonomously navigating through a maze of fragile China vases

‘Amazon Style,’ Amazon’s first clothing retail store opened in Los Angeles, and will use machine-learning technology to help customers find clothes and personalize recommendations.

This NYC hotel offers bookings via NFT that couples room stays and digital assets. We are deleting previous tweets containing a video to correct the number of guest rooms and Sharon Raz’s title

Stocks climb and dollar pares gains after the Fed minutes. We break it all down on The Countdown to The Close

Web Analytics Made Easy - Statcounter